These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 1697623)

  • 41. A pharmacological, pharmacokinetic and clinical overview of risperidone, a new antipsychotic that blocks serotonin 5-HT2 and dopamine D2 receptors.
    He H; Richardson JS
    Int Clin Psychopharmacol; 1995 Mar; 10(1):19-30. PubMed ID: 7542676
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 5-HT2 receptor antagonists reverse amphetamine-induced slowing of dopaminergic neurons by interfering with stimulated dopamine synthesis.
    Sorensen SM; Humphreys TM; Taylor VL; Schmidt CJ
    J Pharmacol Exp Ther; 1992 Feb; 260(2):872-8. PubMed ID: 1531362
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risperidone prevents the development of supersensitivity, but not tolerance, to phencyclidine in rats treated with subacute phencyclidine.
    Kitaichi K; Yamada K; Yoneda Y; Ogita K; Hasegawa T; Furukawa H; Nabeshima T
    Life Sci; 1995; 56(7):531-43. PubMed ID: 7532775
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of 5-HT1A agonists and 5-HT2 antagonists on haloperidol-induced dyskinesias in squirrel monkeys: no evidence for reciprocal 5-HT-dopamine interaction.
    Liebman JM; Gerhardt SC; Gerber R
    Psychopharmacology (Berl); 1989; 97(4):456-61. PubMed ID: 2524857
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The serotonin 5-HT(2A) receptor subtype does not mediate apomorphine-induced aggressive behaviour in male Wistar rats.
    Skrebuhhova-Malmros T; Pruus K; Rudissaar R; Allikmets L; Matto V
    Pharmacol Biochem Behav; 2000 Oct; 67(2):339-43. PubMed ID: 11124399
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mixed D2/5-HT2 antagonism differentially affects apomorphine- and amphetamine-induced stereotyped behavior.
    Feldman DJ; Frank RA; Kehne JH; Flannery R; Brown D; Soni S; Byrd G; Shah S
    Pharmacol Biochem Behav; 1997 Oct; 58(2):565-72. PubMed ID: 9300620
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serotonin-dopamine antagonism ameliorates impairments of spontaneous alternation and locomotor hyperactivity induced by repeated electroconvulsive seizures in rats.
    Hidaka N; Suemaru K; Araki H
    Epilepsy Res; 2010 Aug; 90(3):221-7. PubMed ID: 20605414
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacological profile of MS-377, a novel antipsychotic agent with selective affinity for sigma receptors.
    Takahashi S; Sonehara K; Takagi K; Miwa T; Horikomi K; Mita N; Nagase H; Iizuka K; Sakai K
    Psychopharmacology (Berl); 1999 Aug; 145(3):295-302. PubMed ID: 10494578
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vivo dopamine-D2 and serotonin-5-HT2 receptor binding study of risperidone and haloperidol.
    Sumiyoshi T; Kido H; Sakamoto H; Urasaki K; Suzuki K; Yamaguchi N; Mori H; Shiba K; Yokogawa K
    Pharmacol Biochem Behav; 1994 Mar; 47(3):553-7. PubMed ID: 7516078
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Behavioral patterns related to dopamine neurotransmission: effect of acute and chronic antipsychotic drugs.
    Ungerstedt U; Ljungberg T
    Adv Biochem Psychopharmacol; 1977; 16():193-9. PubMed ID: 18882
    [No Abstract]   [Full Text] [Related]  

  • 51. Differential regulation of hippocampal BDNF mRNA by typical and atypical antipsychotic administration.
    Chlan-Fourney J; Ashe P; Nylen K; Juorio AV; Li XM
    Brain Res; 2002 Nov; 954(1):11-20. PubMed ID: 12393228
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: ritanserin and setoperone.
    Leysen JE; Van Gompel P; Gommeren W; Woestenborghs R; Janssen PA
    Psychopharmacology (Berl); 1986; 88(4):434-44. PubMed ID: 3010361
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of ritanserin on haloperidol-induced dopamine (D2) receptor up-regulation in the rat.
    Szczepanik AM; Wilmot CA
    Neurosci Lett; 1997 Aug; 231(2):91-4. PubMed ID: 9291148
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Receptor occupancy by ritanserin and risperidone measured using ex vivo autoradiography.
    Schotte A; de Bruyckere K; Janssen PF; Leysen JE
    Brain Res; 1989 Oct; 500(1-2):295-301. PubMed ID: 2481562
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The 5-HT2 antagonist ritanserin blocks dopamine re-uptake in the rat frontal cortex.
    Ruiu S; Marchese G; Saba PL; Gessa GL; Pani L
    Mol Psychiatry; 2000 Nov; 5(6):673-7. PubMed ID: 11126398
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risperidone and ritanserin but not haloperidol block effect of dizocilpine on the active allothetic place avoidance task.
    Bubenikova-Valesova V; Stuchlik A; Svoboda J; Bures J; Vales K
    Proc Natl Acad Sci U S A; 2008 Jan; 105(3):1061-6. PubMed ID: 18195350
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changes in the sensitivities of dopamine receptors to chronic treatment with imipramine & haloperidol in rats.
    Pradhan N; Arunasmitha AS
    Indian J Med Res; 1990 Aug; 92():293-7. PubMed ID: 2228076
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of ritanserin on the interaction of amfonelic acid and neuroleptic-induced striatal dopamine metabolism.
    Brougham LR; Conway PG; Ellis DB
    Neuropharmacology; 1991 Oct; 30(10):1137-40. PubMed ID: 1684649
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risperidone. A review of its pharmacology and therapeutic potential in the treatment of schizophrenia.
    Grant S; Fitton A
    Drugs; 1994 Aug; 48(2):253-73. PubMed ID: 7527327
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Brexpiprazole has a low risk of dopamine D
    Amada N; Akazawa H; Ohgi Y; Maeda K; Sugino H; Kurahashi N; Kikuchi T; Futamura T
    Neuropsychopharmacol Rep; 2019 Dec; 39(4):279-288. PubMed ID: 31487433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.